Clinical Trial Update: Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients

View source ↗

Summary

Clinical trial update examining effectiveness and safety of brand-name versus generic palbociclib in Iraqi patients with stage IV breast cancer; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)
• Palbociclib (generic) (palbociclib)

Snippet

Sponsor: Al-Mustansiriyah University | Conditions: Brest Cancer, CDK4/6 Inhibitor | Status: ACTIVE_NOT_RECRUITING